Form 4: Vita Coco Company Executive Jane Prior Executes Stock Options and Sells Shares
SEC Form 4 Filing
Jane Prior, Chief Marketing Officer of Vita Coco Company, exercised stock options and sold 20,000 shares of common stock on November 1st and 4th, 2024, according to a Form 4 filing.
Summary
- Jane Prior, the Chief Marketing Officer of Vita Coco Company, Inc., engaged in transactions involving the company's stock.
- On November 1st and 4th, 2024, Prior exercised non-qualified stock options to acquire 20,000 shares at a price of $10.178 per share.
- Simultaneously, Prior sold 20,000 shares of common stock on the same days at prices of $32.112 and $35 per share, respectively.
- Following these transactions, Prior directly owns 131,834 shares of Vita Coco Company, Inc.
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating routine stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. Rule 10b5-1 plans are frequently used to allow insiders to sell shares without being accused of trading on non-public information.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- The vesting schedules and exercise prices of these options are typically benchmarked against industry peers to ensure competitiveness.
- Sales under 10b5-1 plans are a common practice among executives at publicly traded companies, including competitors like National Beverage Corp. (FIZZ) and Keurig Dr Pepper (KDP).
Stakeholder Impact
- The stock sales may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
- The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2024-10-01 | Date of Power of Attorney execution. |
| 2024-11-01 | Date of stock option exercise and share sale. |
| 2024-11-04 | Date of stock option exercise and share sale. |
| 2030-02-10 | Expiration date of Non-Qualified Stock Option. |
| 2029-12-16 | Expiration date of Non-Qualified Stock Option. |
| 2031-01-11 | Expiration date of Non-Qualified Stock Option. |
| 2031-10-21 | Expiration date of Non-Qualified Stock Option. |
| 2032-08-15 | Expiration date of Non-Qualified Stock Option. |
| 2033-03-10 | Expiration date of Non-Qualified Stock Option. |
| 2034-03-04 | Expiration date of Non-Qualified Stock Option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.